Serum and plasma samples from three healthy volunteers were diluted to contain different levels of endogenous CL-11 and spiked with DG44 CHO cell culture supernatant containing recombinant CL-11. Recovery was calculated as the ratio of measured CL-11 over the expected total CL-11 concentration. Intraassay variation was calculated by running the QCs in 22 replicates on a single plate. The interassay variation was determined by running the QCs in triplicates on ten plates on five separate occasions. Intra- and interassay CVs < 10% were found acceptable. Selleckchem Epigenetics Compound Library Serum
and plasma samples (250 μl aliquots) from five different healthy persons were stored at room temperature, 4 °C and − 20 °C for 1 week. CL-11 levels were measured after 24 h and after 1 week
of storage. Furthermore, CL-11 was measured in samples stored at − 20 °C and − 80 °C for one month. The fresh sample aliquots were also subjected to eight freeze-thaw cycles (− 20 °C and room temperature, respectively) and CL-11 levels were measured after 1, 2, 3, 4 and 8 freeze-thaw cycles. Matched serum and EDTA-plasma samples collected from 100 Danish blood donors and serum samples from two individuals affected by 3MC syndrome, who carry a homozygous mutation in COLEC11 (p.Gly204Ser), were tested in ELISA in triplicates at a dilution of 1/40 and 1/14, respectively. The normality of the data was evaluated using the Shapiro–Wilk test. The Altman–Bland see more method was used to assess differences in CL-11 concentrations between the matched serum and plasma samples. EDTA-plasma from two healthy individuals was depleted for CL-11 by passage through an anti-CL-11 MAbs column (4 different anti-CL-11 MAbs conjugated to Sepharose) and tested in ELISA in triplicates at a dilution of 1/10 or 1/20. The specificity of MAbs 11–2 and 14–29 was analyzed Loperamide by Western blotting. To mimic the
ELISA setup, bound serum antigens were eluted from microtiter wells coated with MAb 11–2 and analyzed by Western blotting using biotinylated MAbs 14–29 and 11–2 (Fig. 1A). By this approach, a protein band of 34 kDa, corresponding to full-length CL-11, was detected in reduced eluates. The biotinylated MAb 14–29 reacted only weakly with reduced CL-11. Under nonreduced conditions immunoreactivity bands at 200 and 300 kDa were detected, corresponding to dimers and trimers of subunits of CL-11, as well as several oligomers larger than 300 kDa. In addition, a faint band of approximately 28 kDa (not detected with MAb 14–29) and a band of approximately 160 kDa were detected in the reduced and nonreduced eluates, respectively. These bands also developed with other anti-CL-11 MAbs (data not shown) and therefore we speculate that they also represent CL-11 (see discussion). From a panel of 50 mouse anti-human CL-11 MAbs recognizing at least seven different epitopes of CL-11, MAb 11–2 and biotinylated 14–29 were chosen for capture and detection, respectively.